Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Merab Kokaia

Showing results (61-70 of 79) with videos related to

Pageof 8
Sort By:
Stem Cell Reports|June 24, 2022
Transcription factor-based direct conversion of human fibroblasts to functional astrocytesElla Quist, Francesco Trovato, Natalia Avaliani, et al.
Scientific Reports|December 20, 2019
Inhibition of epileptiform activity by neuropeptide Y in brain tissue from drug-resistant temporal lobe epilepsy patientsJenny Wickham, Marco Ledri, Johan Bengzon, et al.
Frontiers in Molecular Neuroscience|December 21, 2020
Gene Therapy Vector Encoding Neuropeptide Y and Its Receptor Y2 for Future Treatment of Epilepsy: Preclinical Data in RatsJulia Alicja Szczygieł, Kira Iben Danielsen, Esbjörn Melin, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|January 23, 2019
Long-Term, Targeted Delivery of GDNF from Encapsulated Cells Is Neuroprotective and Reduces Seizures in the Pilocarpine Model of EpilepsyGiovanna Paolone, Chiara Falcicchia, Francesca Lovisari, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 15, 2025
AAV-mediated gene therapy for focal epilepsy by expressing neuropeptide Y and Y2 receptor in rodent and non-human primate hippocampusBarbara Terzic, Esbjörn Melin, Pernilla Fagergren, et al.
Gene Therapy|October 25, 2024
Chemogenetics with PSAM<sup>4</sup>-GlyR decreases excitability and epileptiform activity in epileptic hippocampusAna Gonzalez-Ramos, Fredrik Berglind, Jan Kudláček, et al.
Epilepsia|August 6, 2013
Epilepsy therapy development: technical and methodologic issues in studies with animal modelsAristea S Galanopoulou, Merab Kokaia, Jeffrey A Loeb, et al.
Epilepsy Research|December 22, 2022
Shaping the future of European epilepsy research: Final meeting report from EPICLUSTERDavid C Henshall, Alexis Arzimanoglou, Stefanie Dedeurwaerdere, et al.
Scientific Reports|April 22, 2016
Optogenetic control of human neurons in organotypic brain culturesMy Andersson, Natalia Avaliani, Andreas Svensson, et al.
International Journal of Molecular Sciences|November 11, 2022
GDNF Increases Inhibitory Synaptic Drive on Principal Neurons in the Hippocampus via Activation of the Ret PathwayApostolos Mikroulis, Eliška Waloschková, Johan Bengzon, et al.
Pageof 8

Showing results (61-70 of 79) with videos related to

Sort By:
Pageof 8
Stem Cell Reports|June 24, 2022
Transcription factor-based direct conversion of human fibroblasts to functional astrocytesElla Quist, Francesco Trovato, Natalia Avaliani, et al.
Scientific Reports|December 20, 2019
Inhibition of epileptiform activity by neuropeptide Y in brain tissue from drug-resistant temporal lobe epilepsy patientsJenny Wickham, Marco Ledri, Johan Bengzon, et al.
Frontiers in Molecular Neuroscience|December 21, 2020
Gene Therapy Vector Encoding Neuropeptide Y and Its Receptor Y2 for Future Treatment of Epilepsy: Preclinical Data in RatsJulia Alicja Szczygieł, Kira Iben Danielsen, Esbjörn Melin, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|January 23, 2019
Long-Term, Targeted Delivery of GDNF from Encapsulated Cells Is Neuroprotective and Reduces Seizures in the Pilocarpine Model of EpilepsyGiovanna Paolone, Chiara Falcicchia, Francesca Lovisari, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 15, 2025
AAV-mediated gene therapy for focal epilepsy by expressing neuropeptide Y and Y2 receptor in rodent and non-human primate hippocampusBarbara Terzic, Esbjörn Melin, Pernilla Fagergren, et al.
Gene Therapy|October 25, 2024
Chemogenetics with PSAM<sup>4</sup>-GlyR decreases excitability and epileptiform activity in epileptic hippocampusAna Gonzalez-Ramos, Fredrik Berglind, Jan Kudláček, et al.
Epilepsia|August 6, 2013
Epilepsy therapy development: technical and methodologic issues in studies with animal modelsAristea S Galanopoulou, Merab Kokaia, Jeffrey A Loeb, et al.
Epilepsy Research|December 22, 2022
Shaping the future of European epilepsy research: Final meeting report from EPICLUSTERDavid C Henshall, Alexis Arzimanoglou, Stefanie Dedeurwaerdere, et al.
Scientific Reports|April 22, 2016
Optogenetic control of human neurons in organotypic brain culturesMy Andersson, Natalia Avaliani, Andreas Svensson, et al.
International Journal of Molecular Sciences|November 11, 2022
GDNF Increases Inhibitory Synaptic Drive on Principal Neurons in the Hippocampus via Activation of the Ret PathwayApostolos Mikroulis, Eliška Waloschková, Johan Bengzon, et al.
Pageof 8